As part of our series focussing on medicines available in Australia, we have added a product review examining dupilumab as an add-on therapy for chronic obstructive pulmonary disease.
This review discusses the current treatment landscape in Australia, indications and dosage, contraindications and a series of clinical studies featuring dupilumab. It also provides guidance from Dr Sanjay Ramakrishnan, a consultant respiratory physician at Sir Charles Gairdner Hospital in Nedlands, Western Australia.
Please login below to download this issue (PDF)